Bold approaches in Regulatory - Anonymous employee Sanofi Employee Review

4.0
Mar 22, 2018
Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

I’ve worked at Sanofi for many years and the bold impetus and innovation I’m seeing lately is truly remarkable. In the Regulatory Affairs space, which is where I work, new ideas and technologies are being embraced and tested. A recent pilot on Artificial Intelligence for Regulatory decision-making using machine learning and Natural Language Processing is one such example. This groundbreaking pilot showcased what’s possible when different functions focus on a common goal using the latest new technologies. This is quite exciting and while challenges remain it is one way I see Sanofi striving to transform innovation into dynamic healthcare solutions.

Cons

As with many large matrix companies getting the right alignment requires some effort

Explore other reviews about Sanofi

5.0
Jun 24, 2026
Recommend
CEO approval
Business Outlook

Pros

work life balance, benefits, flexibility

Cons

less competitive salary, less promotion

3.0
Jul 1, 2026
Recommend
CEO approval
Business Outlook

Pros

Extensive and active employee resource groups, strong leadership development opportunities, clear company mission, gig opportunities that support career development, strong employee support through the ombuds office and compliance help line, and stable company portfolio.

Cons

No work-life balance considerations with hybrid work model, contradictions in company mission compared to policies (i.e., target to reduce carbon emissions with employee commuting to office as one of the top 5 causes but yet still requiring employees to commute to office 3 days a week), some office sites are not conducive to in office productivity (not enough privacy or space), compensation package is not competitive for MA pharmaceutical companies, long-term incentives have almost no value once they are vested, health care benefits require employees to jump through hoops to maximize discounts or qualify for coverage of certain medications, and accountability for department leadership to follow the corporate leadership pillars is inconsistent across departments.

See reviews by: Helpful|Rating|Date|All